Endothelin: a potent vasoconstrictor associated with coronary vasospasm.
Endothelin, administered into the coronary arteries of anesthetized dogs, produced a profound and long-lasting reduction in coronary blood flow with electrocardiographical evidence of myocardial ischemia. Coronary angiography revealed delayed filling of the distal branches and, in some cases, cessation of the blood flow distal to the epicardial portions of coronary arteries. The coronary vasoconstriction induced by endothelin subsided after intracoronary administration of nitroglycerin. Pretreatment with the Ca2+-channel antagonist, nitrendipine, suppressed endothelin-induced vasoconstriction. These findings suggest that endothelin, produced by vascular endothelial cells, may contribute to the pathogenesis of coronary vasospasm.
Kurihara
H
H
Third Department of Internal Medicine, University of Tokyo, Japan.
Yamaoki
K
K
Nagai
R
R
Yoshizumi
M
M
Takaku
F
F
Satoh
H
H
Inui
J
J
Yazaki
Y
Y
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000187:drug effects; D003329:Coronary Vasospasm / Q000503:physiopathology*; D004285:Dogs; D016232:Endothelins; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009568:Nitrendipine / Q000494:pharmacology; D010455:Peptides / Q000502:physiology*; D014662:Vasoconstrictor Agents
D016232:Endothelins; D010455:Peptides; D014662:Vasoconstrictor Agents; D009568:Nitrendipine